Ameeri Suhaila, Butany Jagdish, Collins Michael J, Nair Vidhya, Korosh Khalili, Kandel Rita, Rubin Barry
Department of Pathology, Toronto Medical Laboratories, Toronto General Hospital/University Health Network, Toronto, Ontario, Canada.
Cardiovasc Pathol. 2006 May-Jun;15(3):171-3. doi: 10.1016/j.carpath.2005.08.011.
Leiomyosarcoma of the inferior vena cava is a rare neoplasm; however, it is the most frequent tumor of vascular origin. It is classified according to site of origin that reflects its clinical presentation and prognosis. They are generally recognized to be of smooth muscle cell origin. Surgical resection is the treatment of choice. The role of adjuvant therapy for leiomyosarcoma is not established.
